Fig. 3From: Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in KoreaProgression-free survival (a) and overall survival (b) in patients with cancers of the oral cavity and oropharynx treated with immune checkpoint inhibitors according to the HPV expression. HPV human papillomavirusBack to article page